On November 15, 2019, Fermi Instruments and Scienta Omicron reached a cooperation agreement on the development of ARPES cryogenic sample holders and APXPS systems, which will start from the Chinese market and target the global market. Fermi Instruments has its own unique advantages in the fields of ultra-high vacuum system integration and cryogenic technology, while Scienta Omicron has profound attainments in spectroscopy research. The cutting-edge technologies of both parties complement each other and will bring new impetus to exploring the boundaries of scientific research.
Based on a long-standing production partnership based on a shared customer focus and commitment to joint technology development, Fe-Mian Instruments and Scienta Omicron have signed a new agreement to further their partnership, working together to provide R&D institutions with highly reliable, flexible and easy-to-use products.
About Fe-Mian InstrumentsHeadquartered in Shanghai, China, Fe-Mian Instruments is one of the most creative and innovative manufacturers of vacuum ultraviolet sources, cryogenic components, and ultra-high vacuum systems and components. Since its founding by condensed matter physicists, Fe-Mian Instruments has been committed to developing novel system solutions to advance surface science and materials physics at the forefront of science.
About Scienta Omicron
Founded by Nobel Prize winner Professor Kai Siegbahn, Scienta Omicron, located in Sweden and Germany, provides Nobel Prize-winning technology to research and industry. Since its founding in 1983, Scienta Omicron has been an innovator in electron spectroscopy, scanning probe microscopy and ultra-high vacuum thin film deposition; its materials innovation platform provides researchers around the world with a variety of support to gain an advantage in the global innovation race in areas such as smart batteries, next-generation electronics, quantum technologies, solar energy, etc.
More information:
Fermi Instruments – www.fermi.com
Dr. Hongwei OU, hongwei.ou@fermi.com
Scienta Omicron – www.scientaomicron.com
Dr. Marcus Lundwall, marcus.lundwall@scientaomicron.com